|
|
| Vitamines - Compléments Alimentaires > Etude de marché sectorielle |
| OTC Healthcare in Canada to 2010 |
|
|
|
|
€ 396,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
162 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
OTC Vitamins and Dietary Supplements in Germany
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in Germany' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line ov |
198,00 €
|
| |
| |
Nutraceuticals in Germany
18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and segmentat |
160,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
Future Health Trends in Food and Drinks: Growth opportunities in daily dosing, GI, heart health, right fats and phood
196 pages | Août 2005 |
The GI diet is being driven due to rising obesity, rising diabetes and because the diet can be essentially seen as a sophistication of the Atkins diet; manufacturers are driving the trend by tailoring |
1 623,50 €
|
| |
| |
Herbal Supplements and Remedies
315 pages | Août 2006 |
This report analyzes the worldwide markets for Herbal Supplements and Remedies in Millions of US$.
The Major product segments analyzed are Ginkgo Biloba, Garlic, Ginseng, Echinacea, St.
John's W |
3 160,00 €
|
| |
| |
Herbal Supplements and Remedies
279 pages | Octobre 2005 |
This report analyzes the worldwide markets for Herbal Supplements and Remedies in Millions of US$.
Major product segments analyzed are Ginkgo Biloba, Garlic, Ginseng, Echinacea, St.
John's Wort, |
3 091,00 €
|
| |
| |
OTC Vitamins and Dietary Supplements in the United Kingdom
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in the UK' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line ove |
198,00 €
|
| |
| |
Innovation in Natural and Organic Food and Drinks: Winning NPD strategies and future trends in healthy and ethical products
122 pages | Mai 2006 |
The terms natural and organic are not mutually exclusive: many products are marketed as ‘natural’ without organic certification; likewise, a number of organic products do not incorporate the term ‘nat |
1 528,00 €
|
| |
| |
Nutraceuticals in France
18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in France industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and segmentati |
160,00 €
|
| |
| |
UK Functional Foods
178 pages | Janvier 2007 |
Functional foods — i.e.
those that claim to have other health benefits in addition to their nutritional value — tend to be promoted mainly as being able to help prevent heart disease, digestive pro |
1 390,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Healthcare in Canada to 2010 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Canada. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2005 and full forecasts to 2010.
Scope
Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products.Provides market value, volume, expenditure and consumption data by market, segment and subsegment.Includes company and brand share data by category, as well as distribution channel data.Contains market value segmentation by demographic and socioeconomic group.
Highlights
The market for OTC Healthcare in Canada increased between 2000-2005, growing at an average annual rate of 4.8%.
The leading company in the market in 2005 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Jamieson Laboratories in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC Healthcare markets.Understand the future direction of the market with reliable historical data and full five year forecasting.Understand consumers' consumption and expenditure patterns.
|
|
TABLE OF CONTENTS
ABOUT DATAMONITOR 2
TABLE OF CONTENTS 3
LIST OF TABLES 7
LIST OF FIGURES 18
CHAPTER 1 INTRODUCTION 20
What is this report about? 20
How to use this report 20
Definitions 20
CHAPTER 2 CANADA OTC HEALTHCARE 25
2.1 Value 25
2.2 Market Share 33
2.3 Distribution 39
2.4 Expenditure & consumption per head 40
2.5 ConsumerGraphics 44
CHAPTER 3 CANADA ANALGESICS 47
3.1 Value 47
3.2 Market Share 52
3.3 Distribution 54
3.4 Expenditure & consumption per head 55
3.5 ConsumerGraphics 57
CHAPTER 4 CANADA COUGH AND COLD PREPARATIONS 60
4.1 Value 60
4.2 Market Share 66
4.3 Distribution 69
4.4 Expenditure & consumption per head 70
4.5 ConsumerGraphics 73
CHAPTER 5 CANADA INDIGESTION PREPARATIONS 76
5.1 Value 76
5.2 Market Share 81
5.3 Distribution 83
5.4 Expenditure & consumption per head 84
5.5 ConsumerGraphics 86
CHAPTER 6 CANADA MEDICATED SKIN PRODUCTS 89
6.1 Value 89
6.2 Market Share 95
6.3 Distribution 97
6.4 Expenditure & consumption per head 98
6.5 ConsumerGraphics 101
CHAPTER 7 CANADA TRADITIONAL MEDICINES 104
7.1 Value 104
7.2 Market Share 108
7.3 Distribution 110
7.4 Expenditure & consumption per head 111
7.5 ConsumerGraphics 113
CHAPTER 8 CANADA VITAMINS AND MINERALS 116
8.1 Value 116
8.2 Market Share 122
8.3 Distribution 124
8.4 Expenditure & consumption per head 125
8.5 ConsumerGraphics 128
CHAPTER 9 CANADA OTHER OTC HEALTHCARE 131
9.1 Value 131
9.2 Market Share 137
9.3 Distribution 140
9.4 Expenditure & consumption per head 141
9.5 ConsumerGraphics 144
CHAPTER 10 CANADA SOCIOECONOMIC PROFILE 147
10.1 Country Overview 147
10.2 Key Facts 148
10.3 Political Overview 149
10.4 Canada Economic Overview 150
CHAPTER 11 CANADA MACROECONOMIC PROFILE 151
11.1 Macroeconomic Indicators 151
CHAPTER 12 RESEARCH METHODOLOGY 157
12.1 Methodology overview 157
12.2 Secondary research 158
12.3 Market modelling 159
12.4 Primary research 160
12.5 Data finalisation 161
12.6 Ongoing research 161
CHAPTER 13 APPENDIX 162
13.1 Future readings 162
13.2 How to contact experts in your industry 162
LIST OF TABLES
Table 1: OTC Healthcare category definitions 21
Table 2: OTC Healthcare distribution channels 23
Table 3: Canada OTC Healthcare value, 2000-2005 (CAD m, 2005 prices) 25
Table 4: Canada OTC Healthcare value forecast, 2005-2010 (CAD m, 2005 prices) 26
Table 5: Canada OTC Healthcare value, 2000-2005 (CAD m, nominal prices) 28
Table 6: Canada OTC Healthcare value forecast, 2005-2010 (CAD m, nominal prices) 29
Table 7: Canada OTC Healthcare value, 2000-2005 (US$ m nominal prices) 30
Table 8: Canada OTC Healthcare value forecast, 2005-2010 (US$ m nominal prices) 31
Table 9: Canada OTC Healthcare brand share, by value, 2004-2005 (%) 33
Table 10: Canada OTC Healthcare value, by brand, 2004-2005 (CAD m nominal prices) 35
Table 11: Canada OTC Healthcare company share, by value, 2004-2005 (%)` 37
Table 12: Canada OTC Healthcare value, by company, 2004-2005 (CAD m nominal prices) 38
Table 13: Canada OTC Healthcare distribution channels, by value, 2004-2005 (%) 39
Table 14: Canada OTC Healthcare value, by distribution channel, 2004-2005 (CAD m nominal prices) 39
Table 15: Canada OTC Healthcare expenditure per head, 2000-2005 (CAD, 2005 prices) 40
Table 16: Canada OTC Healthcare forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 41
Table 17: Canada OTC Healthcare expenditure per head, 2000-2005 (US$ nominal prices) 42
Table 18: Canada OTC Healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 43
Table 19: Canada OTC Healthcare value, by age group, 2005 44
Table 20: Canada OTC Healthcare value, by income group, 2005 44
Table 21: Canada OTC Healthcare value, by gender, 2005 45
Table 22: Canada OTC Healthcare value, by marital status, 2005 45
Table 23: Canada OTC Healthcare value, by size of household, 2005 45
Table 24: Canada OTC Healthcare value, by urban/rural residence, 2005 46
Table 25: Canada Analgesics value, 2000-2005 (CAD m, 2005 prices) 47
Table 26: Canada Analgesics value forecast, 2005-2010 (CAD m, 2005 prices) 48
Table 27: Canada Analgesics value, 2000-2005 (CAD m, nominal prices) 49
Table 28: Canada Analgesics value forecast, 2005-2010 (CAD m, nominal prices) 49
Table 29: Canada Analgesics value, 2000-2005 (US$ m nominal prices) 50
Table 30: Canada Analgesics value forecast, 2005-2010 (US$ m nominal prices) 50
Table 31: Canada Analgesics brand share, by value, 2004-2005 (%) 52
Table 32: Canada Analgesics value, by brand, 2004-2005 (CAD m nominal prices) 52
Table 33: Canada Analgesics company share, by value, 2004-2005 (%) 53
Table 34: Canada Analgesics value, by company, 2004-2005 (CAD m nominal prices) 53
Table 35: Canada Analgesics distribution channels, by value, 2004-2005 (%) 54
Table 36: Canada Analgesics value, by distribution channel, 2004-2005 (CAD m nominal prices) 54
Table 37: Canada Analgesics expenditure per head, 2000-2005 (CAD, 2005 prices) 55
Table 38: Canada Analgesics forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 55
Table 39: Canada Analgesics expenditure per head, 2000-2005 (US$ nominal prices) 56
Table 40: Canada Analgesics forecast expenditure per head, 2005-2010 (US$ nominal prices) 56
Table 41: Canada Analgesics value, by age group, 2005 57
Table 42: Canada Analgesics value, by income group, 2005 57
Table 43: Canada Analgesics value, by gender, 2005 58
Table 44: Canada Analgesics value, by marital status, 2005 58
Table 45: Canada Analgesics value, by size of household, 2005 58
Table 46: Canada Analgesics value, by urban/rural residence, 2005 59
Table 47: Canada Cough and cold preparations value, 2000-2005 (CAD m, 2005 prices) 60
Table 48: Canada Cough and cold preparations value forecast, 2005-2010 (CAD m, 2005 prices) 61
Table 49: Canada Cough and cold preparations value, 2000-2005 (CAD m, nominal prices) 63
Table 50: Canada Cough and cold preparations value forecast, 2005-2010 (CAD m, nominal prices) 63
Table 51: Canada Cough and cold preparations value, 2000-2005 (US$ m nominal prices) 64
Table 52: Canada Cough and cold preparations value forecast, 2005-2010 (US$ m nominal prices) 64
Table 53: Canada Cough and cold preparations brand share, by value, 2004-2005 (%) 66
Table 54: Canada Cough and cold preparations value, by brand, 2004-2005 (CAD m nominal prices) 67
Table 55: Canada Cough and cold preparations company share, by value, 2004-2005 (%) 68
Table 56: Canada Cough and cold preparations value, by company, 2004-2005 (CAD m nominal prices) 68
Table 57: Canada Cough and cold preparations distribution channels, by value, 2004-2005 (%) 69
Table 58: Canada Cough and cold preparations value, by distribution channel, 2004-2005 (CAD m nominal prices) 69
Table 59: Canada Cough and cold preparations expenditure per head, 2000-2005 (CAD, 2005 prices) 70
Table 60: Canada Cough and cold preparations forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 71
Table 61: Canada Cough and cold preparations expenditure per head, 2000-2005 (US$ nominal prices) 72
Table 62: Canada Cough and cold preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 72
Table 63: Canada Cough and cold preparations value, by age group, 2005 73
Table 64: Canada Cough and cold preparations value, by income group, 2005 73
Table 65: Canada Cough and cold preparations value, by gender, 2005 74
Table 66: Canada Cough and cold preparations value, by marital status, 2005 74
Table 67: Canada Cough and cold preparations value, by size of household, 2005 74
Table 68: Canada Cough and cold preparations value, by urban/rural residence, 2005 75
Table 69: Canada Indigestion preparations value, 2000-2005 (CAD m, 2005 prices) 76
Table 70: Canada Indigestion preparations value forecast, 2005-2010 (CAD m, 2005 prices) 76
Table 71: Canada Indigestion preparations value, 2000-2005 (CAD m, nominal prices) 78
Table 72: Canada Indigestion preparations value forecast, 2005-2010 (CAD m, nominal prices) 78
Table 73: Canada Indigestion preparations value, 2000-2005 (US$ m nominal prices) 79
Table 74: Canada Indigestion preparations value forecast, 2005-2010 (US$ m nominal prices) 79
Table 75: Canada Indigestion preparations brand share, by value, 2004-2005 (%) 81
Table 76: Canada Indigestion preparations value, by brand, 2004-2005 (CAD m nominal prices) 81
Table 77: Canada Indigestion preparations company share, by value, 2004-2005 (%) 82
Table 78: Canada Indigestion preparations value, by company, 2004-2005 (CAD m nominal prices) 82
Table 79: Canada Indigestion preparations distribution channels, by value, 2004-2005 (%) 83
Table 80: Canada Indigestion preparations value, by distribution channel, 2004-2005 (CAD m nominal prices) 83
Table 81: Canada Indigestion preparations expenditure per head, 2000-2005 (CAD, 2005 prices) 84
Table 82: Canada Indigestion preparations forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 84
Table 83: Canada Indigestion preparations expenditure per head, 2000-2005 (US$ nominal prices) 85
Table 84: Canada Indigestion preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 85
Table 85: Canada Indigestion preparations value, by age group, 2005 86
Table 86: Canada Indigestion preparations value, by income group, 2005 86
Table 87: Canada Indigestion preparations value, by gender, 2005 87
Table 88: Canada Indigestion preparations value, by marital status, 2005 87
Table 89: Canada Indigestion preparations value, by size of household, 2005 87
Table 90: Canada Indigestion preparations value, by urban/rural residence, 2005 88
Table 91: Canada Medicated skin products value, 2000-2005 (CAD m, 2005 prices) 89
Table 92: Canada Medicated skin products value forecast, 2005-2010 (CAD m, 2005 prices) 90
Table 93: Canada Medicated skin products value, 2000-2005 (CAD m, nominal prices) 92
Table 94: Canada Medicated skin products value forecast, 2005-2010 (CAD m, nominal prices) 92
Table 95: TypeTableTitleHere Canada Medicated skin products value, 2000-2005 (US$ m nominal prices) 93
Table 96: Canada Medicated skin products value forecast, 2005-2010 (US$ m nominal prices) 93
Table 97: Canada Medicated skin products brand share, by value, 2004-2005 (%) 95
Table 98: Canada Medicated skin products value, by brand, 2004-2005 (CAD m nominal prices) 95
Table 99: Canada Medicated skin products company share, by value, 2004-2005 (%) 96
Table 100: Canada Medicated skin products value, by company, 2004-2005 (CAD m nominal prices) 96
Table 101: Canada Medicated skin products distribution channels, by value, 2004-2005 (%) 97
Table 102: Canada Medicated skin products value, by distribution channel, 2004-2005 (CAD m nominal prices) 97
Table 103: Canada Medicated skin products expenditure per head, 2000-2005 (CAD, 2005 prices) 98
Table 104: Canada Medicated skin products forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 99
Table 105: Canada Medicated skin products expenditure per head, 2000-2005 (US$ nominal prices) 100
Table 106: Canada Medicated skin products forecast expenditure per head, 2005-2010 (US$ nominal prices) 100
Table 107: Canada Medicated skin products value, by age group, 2005 101
Table 108: Canada Medicated skin products value, by income group, 2005 101
Table 109: Canada Medicated skin products value, by gender, 2005 102
Table 110: Canada Medicated skin products value, by marital status, 2005 102
Table 111: Canada Medicated skin products value, by size of household, 2005 102
Table 112: Canada Medicated skin products value, by urban/rural residence, 2005 103
Table 113: Canada Traditional medicines value, 2000-2005 (CAD m, 2005 prices) 104
Table 114: Canada Traditional medicines value forecast, 2005-2010 (CAD m, 2005 prices) 104
Table 115: Canada Traditional medicines value, 2000-2005 (CAD m, nominal prices) 106
Table 116: Canada Traditional medicines value forecast, 2005-2010 (CAD m, nominal prices) 106
Table 117: Canada Traditional medicines value, 2000-2005 (US$ m nominal prices) 107
Table 118: Canada Traditional medicines value forecast, 2005-2010 (US$ m nominal prices) 107
Table 119: Canada Traditional medicines brand share, by value, 2004-2005 (%) 108
Table 120: Canada Traditional medicines value, by brand, 2004-2005 (CAD m nominal prices) 108
Table 121: Canada Traditional medicines company share, by value, 2004-2005 (%) 109
Table 122: Canada Traditional medicines value, by company, 2004-2005 (CAD m nominal prices) 109
Table 123: Canada Traditional medicines distribution channels, by value, 2004-2005 (%) 110
Table 124: Canada Traditional medicines value, by distribution channel, 2004-2005 (CAD m nominal price) 110
Table 125: Canada Traditional medicines expenditure per head, 2000-2005 (CAD, 2005 prices) 111
Table 126: Canada Traditional medicines forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 111
Table 127: Canada Traditional medicines expenditure per head, 2000-2005 (US$ nominal prices) 112
Table 128: Canada Traditional medicines forecast expenditure per head, 2005-2010 (US$ nominal prices) 112
Table 129: Canada Traditional medicines value, by age group, 2005 113
Table 130: Canada Traditional medicines value, by income group, 2005 113
Table 131: Canada Traditional medicines value, by gender, 2005 114
Table 132: Canada Traditional medicines value, by marital status, 2005 114
Table 133: Canada Traditional medicines value, by size of household, 2005 114
Table 134: Canada Traditional medicines value, by urban/rural residence, 2005 115
Table 135: Canada Vitamins and minerals value, 2000-2005 (CAD m, 2005 prices) 116
Table 136: Canada Vitamins and minerals value forecast, 2005-2010 (CAD m, 2005 prices) 117
Table 137: Canada Vitamins and minerals value, 2000-2005 (CAD m, nominal prices) 119
Table 138: Canada Vitamins and minerals value forecast, 2005-2010 (CAD m, nominal prices) 119
Table 139: Canada Vitamins and minerals value, 2000-2005 (US$ m nominal prices) 120
Table 140: Canada Vitamins and minerals value forecast, 2005-2010 (US$ m nominal prices) 120
Table 141: Canada Vitamins and minerals brand share, by value, 2004-2005 (%) 122
Table 142: Canada Vitamins and minerals value, by brand, 2004-2005 (CAD m nominal prices) 122
Table 143: Canada Vitamins and minerals company share, by value, 2004-2005 (%) 123
Table 144: Canada Vitamins and minerals value, by company, 2004-2005 (CAD m nominal prices) 123
Table 145: Canada Vitamins and minerals distribution channels, by value, 2004-2005 (%) 124
Table 146: Canada Vitamins and minerals value, by distribution channel, 2004-2005 (CAD m nominal price) 124
Table 147: Canada Vitamins and minerals expenditure per head, 2000-2005 (CAD, 2005 prices) 125
Table 148: Canada Vitamins and minerals forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 126
Table 149: Canada Vitamins and minerals expenditure per head, 2000-2005 (US$ nominal prices) 127
Table 150: Canada Vitamins and minerals forecast expenditure per head, 2005-2010 (US$ nominal prices) 127
Table 151: Canada Vitamins and minerals value, by age group, 2005 128
Table 152: Canada Vitamins and minerals value, by income group, 2005 128
Table 153: Canada Vitamins and minerals value, by gender, 2005 129
Table 154: Canada Vitamins and minerals value, by marital status, 2005 129
Table 155: Canada Vitamins and minerals value, by size of household, 2005 129
Table 156: Canada Vitamins and minerals value, by urban/rural residence, 2005 130
Table 157: Canada Other OTC healthcare value, 2000-2005 (CAD m, 2005 prices) 131
Table 158: Canada Other OTC healthcare value forecast, 2005-2010 (CAD m, 2005 prices) 132
Table 159: Canada Other OTC healthcare value, 2000-2005 (CAD m, nominal prices) 134
Table 160: Canada Other OTC healthcare value forecast, 2005-2010 (CAD m, nominal prices) 134
Table 161: Canada Other OTC healthcare value, 2000-2005 (US$ m nominal prices) 135
Table 162: Canada Other OTC healthcare value forecast, 2005-2010 (US$ m nominal prices) 135
Table 163: Canada Other OTC healthcare brand share, by value, 2004-2005 (%) 137
Table 164: Canada Other OTC healthcare value, by brand, 2004-2005 (CAD m nominal prices) 138
Table 165: Canada Other OTC healthcare company share, by value, 2004-2005 (%) 139
Table 166: Canada Other OTC healthcare value, by company, 2004-2005 (CAD m nominal prices) 139
Table 167: Canada Other OTC healthcare distribution channels, by value, 2004-2005 (%) 140
Table 168: Canada Other OTC healthcare value, by distribution channel, 2004-2005 (CAD m nominal prices) 140
Table 169: Canada Other OTC healthcare expenditure per head, 2000-2005 (CAD, 2005 prices) 141
Table 170: Canada Other OTC healthcare forecast expenditure per head, 2005-2010 (CAD, 2005 prices) 142
Table 171: Canada Other OTC healthcare expenditure per head, 2000-2005 (US$ nominal prices) 143
Table 172: Canada Other OTC healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 143
Table 173: Canada Other OTC healthcare value, by age group, 2005 144
Table 174: Canada Other OTC healthcare value, by income group, 2005 144
Table 175: Canada Other OTC healthcare value, by gender, 2005 145
Table 176: Canada Other OTC healthcare value, by marital status, 2005 145
Table 177: Canada Other OTC healthcare value, by size of household, 2005 145
Table 178: Canada Other OTC healthcare value, by urban/rural residence, 2005 146
Table 179: Canada Key Facts 148
Table 180: Canada population, by age group, 2000-2005 (millions) 151
Table 181: Canada population forecast, by age group, 2005-2010 (millions) 152
Table 182: Canada population, by gender, 2000-2005 (millions) 152
Table 183: Canada population forecast, by gender, 2005-2010 (millions) 153
Table 184: Canada real GDP, 2000-2005 (C $ bn, 2005 prices) 153
Table 185: Canada real GDP forecast, 2005-2010 (C $ bn, 2005 prices) 153
Table 186: Canada nominal GDP, 2000-2005 (C $ bn, nominal prices) 154
Table 187: Canada nominal GDP forecast, 2005-2010 (C $ bn, nominal prices) 154
Table 188: Canada real GDP, 2000-2005 (US$ bn, 2005 prices) 154
Table 189: Canada real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 155
Table 190: Canada consumer price index, 2000-2005 (2000=100) 155
Table 191: Canada consumer price index, 2005-2010 (2000=100) 155
Table 192: Canada exchange rate, 2000-2005 156
LIST OF FIGURES
Figure 1: Canada OTC Healthcare value & value forecast, 2000-2010 (CAD m, 2005 prices) 27
Figure 2: Canada OTC Healthcare category growth comparison, by value, 2000-2010 32
Figure 3: Canada Analgesics value & value forecast, 2000-2010 (CAD m, 2005 prices) 48
Figure 4: Canada Analgesics segment growth comparison, by value, 2000-2010 51
Figure 5: Canada Cough and cold preparations value & value forecast, 2000-2010 (CAD m, 2005 prices) 62
Figure 6: Canada Cough and cold preparations segment growth comparison, by value, 2000-2010 65
Figure 7: Canada Indigestion preparations value & value forecast, 2000-2010 (CAD m, 2005 prices) 77
Figure 8: Canada Indigestion preparations segment growth comparison, by value, 2000-2010 80
Figure 9: Canada Medicated skin products value & value forecast, 2000-2010 (CAD m, 2005 prices) 91
Figure 10: Canada Medicated skin products segment growth comparison, by value, 2000-2010 94
Figure 11: Canada Traditional medicines value & value forecast, 2000-2010 (CAD m, 2005 prices) 105
Figure 12: Canada Vitamins and minerals value & value forecast, 2000-2010 (CAD m, 2005 prices) 118
Figure 13: Canada Vitamins and minerals segment growth comparison, by value, 2000-2010 121
Figure 14: Canada Other OTC healthcare value & value forecast, 2000-2010 (CAD m, 2005 prices) 133
Figure 15: Canada Other OTC healthcare segment growth comparison, by value, 2000-2010 136
Figure 16: Map of Canada 148
Figure 17: Annual data review process 158
|
|
|
PPLSEN
|
|
|
|
|
